Online Trial Tracker - Larvol Sigma

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

hydrocortisone / Generic mfg.

CORVICTES, NCT03592693: Vitamin C, Hydrocortisone and Thiamine for Septic Shock

Recruiting

400

Europe

Combined Vitamin C and Stress-Dose Hydrocortisone, Vitamin-Steroid, Placebo plus placebo, Pacebo

University of Athens, General Hospital of Nikaia "Saint Panteleimon", Naval Hospital, Athens

Shock, Septic

12/25

CRISP, NCT05160506: Corticosteroids to Treat Pancreatitis

Recruiting

Hydrocortisone, Cortef, Cortisol, Hydrocort, Placebo, Normal Saline, 0.9% NACL

Beth Israel Deaconess Medical Center

Pancreatitis, Pancreatitis, Acute, Corticosteroid, Hydrocortisone

01/27

04/27

NCT03286634: ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016

Recruiting

Japan, RoW

Daunorubicin, DNR, Prednisolone, Pred, Vincristine, VCR, Epirubicin, EPI, E-coli L-asparaginase, E-coli L-Asp, 6-Mercaptopurine, 6-MP, Methotrexate, MTX, Hydrocortisone, Cytarabine, Ara-C, Cyclophosphamide, Cy

National Hospital Organization Nagoya Medical Center

Down Syndrome, Acute Lymphoblastic Leukemia, Childhood Cancer

03/28

03/33

NCT02553460: Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I

Active, not recruiting

1/2

Canada, US

ITMHA, Intrathecal Triples, Methotrexate/hydrocortisone/cytarabine, Dexamethasone, Decadron®, Hexadrol®, Dexone®, Dexameth®, Mitoxantrone, Novantrone®, Mitozantrone, Pegaspargase, PEG-asparaginase, Oncaspar®, Asparaginase Erwinia Chrysanthemi, Erwinia chrysanthemi, Erwinase®, Erwinaze^T^M, Crisantaspase, Bortezomib, Velcade®, PS-341, MLN341, LDP-341, Vorinostat, Solinza®, Suberoylanidide Hydroxamic Acid, SAHA, Cyclophosphamide, Cytoxan®, Mercaptopurine, 6-MP, Purinethol®, Methotrexate, MTX, High Dose MTX, Leucovorin Calcium, Wellcovorin®, Folinic acid, Cytarabine, Ara-C, Cytosar-U®, Etoposide, VP-16, Vepesid®, Vincristine, Oncovin®

St. Jude Children's Research Hospital, Gateway for Cancer Research, Baylor College of Medicine

Acute Lymphoblastic Leukemia

05/22

10/31

T2017-002, NCT03817320 / 2019-001947-28: PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

Active, not recruiting

1/2

US, RoW

Ixazomib, Vincristine, Dexamethasone, Asparaginase, Doxorubicin, Methotrexate (IT), Triple IT (Methotrexate, Hydrocortisone, Cytarabine), Leucovorin

Therapeutic Advances in Childhood Leukemia Consortium, Takeda, Children's Hospital Los Angeles

ALL, Childhood, Lymphoblastic Lymphoma, Childhood, Lymphoblastic Leukemia, Acute, Childhood

12/24

06/25

NCT05192889: Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax

Active, not recruiting

1/2

Venetoclax, Venclextra®, ABT-199, Navitoclax, ABT-263, Dexamethasone, Decadron®, Hexadrol®, Dexameth®, Vincristine, Vincristine sulfate, Oncovin®, Calaspargase Pegol, Asparlas, Dasatinib, Sprycel®, Cytarabine, Ara-C, Cytosar-U®, Blinatumomab, Blincyto®, Methotrexate, MTX, Trexall®, amethopterin, Mercaptopurine, 6-MP, Purinethol®, Cyclophosphamide, Cytoxan®, Etoposide, VP-16, Vepesid®, Leucovorin, Folinic acid, Intrathecal Triples, ITMHA, methotrexate/hydrocortisone/cytarabine, Pegaspargase, Oncaspar®, PEG-asparaginase, PEG-L-asparaginase, Erwinia asparaginase, Erwinase®, Radiation, Irradiation

St. Jude Children's Research Hospital, AbbVie

Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia

08/25

07/29

NCT05157360: HAT for the Treatment of Sepsis Associated With NASTI

Terminated

1/2

HAT, hydrocortisone, vitamin C, vitamin B1, Placebo, NaCl 0.9%

Ascension Via Christi Hospitals Wichita, Inc., The University of Kansas School of Medicine - Wichita

Necrotizing Soft Tissue Infection, Sepsis

05/23

NCT04501614 / 2019-002549-39: A Study of Ponatinib With Chemotherapy in Children, Teenagers, and Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Active, not recruiting

1/2

Europe, US, RoW

Ponatinib, Ponatinib AAF, Chemotherapy Agents

Takeda, Takeda Development Center Americas, Inc.

Pediatric Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ALL), Ph+ Mixed Phenotype Acute Leukemia (MPAL), Philadelphia Chromosome-Like ALL (Ph-like ALL)

12/24

01/27

CORVICTES Î¥Îœ, NCT03649633: Vitamin C, Steroids, and Thiamine, and Cerebral Autoregulation and Functional Outcome in Septic Shock

Recruiting

1/2

100

Europe

Stress-dose Hydrocortisone plus Vitamin C, Vitamin-Steroid, isotonic sodium chloride solution placebo plus isotonic sodium chloride solution placebo, Placebo-placebo

University of Athens

Septic Shock

05/25

NCT04029688 / 2018-004579-11: A Study Evaluating the Safety, Tolerability, Pharmacokinetics and Preliminary Activity of Idasanutlin in Combination With Either Chemotherapy or Venetoclax in Treatment of Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias or Solid Tumors

Active, not recruiting

1/2

Europe, Canada, US

Idasanutlin, RG7388, Venetoclax, RG7601, GDC-0199, ABT-199, Cyclophosphamide, Topotecan, Fludarabine, Cytarabine, Intrathecal Chemotherapy

Hoffmann-La Roche

Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Neuroblastoma, Solid Tumors

06/24

12/25

NCT03793478 / 2016-002919-18: Safety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood

Recruiting

1/2

Europe, Canada, US, RoW

Quizartinib, Quizartinib dihydrochloride, Vanflyta, Fludarabine, Cytarabine, Intrathecal (IT) triple chemotherapy prophylaxis, Etoposide

Daiichi Sankyo, Inc., Innovative Therapies For Children with Cancer Consortium, Children's Oncology Group

Acute Myeloid Leukemia

05/27

CD2 SCD, NCT06078696: Siplizumab for Sickle Cell Disease Transplant

Recruiting

1/2

Siplizumab, TCD601 (Siplizumab), Exchange Transfusion, Total Body Irradiation, TBI, Stem Cell Infusion, Cyclophosphamide 50mg, Cytoxan, Cytoxan Lyophilized, Mesna, Mesnex, Sirolimus Oral Tablet, Rapamycin, Rapamune, Rituximab or Biosimilar, Riabni, Rituxan, Ruxience, Truxima

Markus Mapara, ITB-Med LLC

Anemia, Sickle Cell

07/28

07/29

HEM-iSMART D, NCT05658640: HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies

Recruiting

1/2

Europe

Trametinib, Dexamethasone, Cyclophosphamide, Cytarabine, Intrathecal chemotherapy

Princess Maxima Center for Pediatric Oncology, Innovative Therapies For Children with Cancer Consortium, IBFM, Fight Kids Cancer

Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory, Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Refractory

04/29

HEM-iSMART A, NCT05740449: HEM-iSMART-A: Decitabine / Venetoclax and Navitoclax in Pediatric Patients With Relapsed or Refractory Hematological Malignancies

Withdrawn

1/2

Europe

Decitabine, Venetoclax, Navitoclax, intrathecal chemotherapy

Princess Maxima Center for Pediatric Oncology, Innovative Therapies For Children with Cancer Consortium, IBFM, Fight Kids Cancer

10/29

HEM-iSMART C, NCT05745714: HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies

Not yet recruiting

1/2

Europe

Ruxolitinib, Venetoclax, Dexamethasone, Cyclophosphamide, Cytarabine, intrathecal chemotherapy

Princess Maxima Center for Pediatric Oncology, Innovative Therapies For Children with Cancer Consortium, IBFM, Fight Kids Cancer

10/31

HEM-iSMART B, NCT05751044: HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies

Not yet recruiting

1/2

Europe

Dasatinib, Venetoclax, Dexamethasone, Cyclophosphamide, Cytarabine, intrathecal chemotherapy

Princess Maxima Center for Pediatric Oncology, Innovative Therapies For Children with Cancer Consortium, IBFM, Fight Kids Cancer

Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory, Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Refractory

10/31

NCT02256865: Hormonal Mechanisms of Sleep Restriction

Completed

Ketoconazole, Nizoral, Hydrocortisone, Cortef, Cortril, Hydrocortone, Testosterone, AndroGel, Placebo for ketoconazole, Placebo for hydrocortisone, Placebo for testosterone

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Insulin Resistance

11/17

10/23

NCT02843854: Safety and Efficacy of Allogeneic MSCs in Promoting T-regulatory Cells in Patients With Small Abdominal Aortic Aneurysms

Not yet recruiting

Intravenous infusion of Plasmalyte A (placebo), Intravenous infusion of 1 million allogeneic MSCs/kg, Intravenous infusion of 3 million allogeneic MSCs/kg

Michael Murphy

AAA, Abdominal Aortic Aneurysm, Vascular Disease, Peripheral Artery Disease

08/19

04/20

NCT03194932: Study of Venetoclax in Combination With Chemotherapy in Pediatric Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Leukemia of Ambiguous Lineage

Completed

Venetoclax, Venclextra®, ABT-199, Cytarabine, Cytosine arabinoside, Ara-C, Cytosar®, Idarubicin, Idamycin PFS, Intrathecal Triple Therapy, ITMHA, methotrexate/hydrocortisone/cytarabine, Azacitidine, VIDAZA®

St. Jude Children's Research Hospital, Gateway for Cancer Research

Acute Myeloid Leukemia

10/20

06/22

NCT03792256: Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL)

Active, not recruiting

Palbociclib, Cytarabine, Methotrexate, Hydrocortisone, Doxorubicin, Prednisolone, Vincristine, Pegaspargase, Prednisone

Children's Oncology Group

Leukemia, Lymphocytic, Lymphoblastic Lymphoma, T-cell Lymphoma, T-cell Leukemia, Recurrent Disease, Acute Leukemia

06/21

06/25

NCT03718234: Subcutaneous Hydrocortisone Children With Congenital Adrenal Hyperplasia

Completed

Subcutaneous hydrocortisone, Hydrocortisone delivered via subcutaneous pump, Standard glucocorticoid therapy

University of Minnesota

Congenital Adrenal Hyperplasia, Hyperplasia, Adrenal Hyperplasia, Congenital Disorders, Adrenocortical Hyperfunction, Disorders of Sex Development, Urogenital Abnormalities, Genetic Diseases, Inborn, Steroid Metabolic Diseases, Inborn, Adrenal Gland Disease, Hydrocortisone

02/23

Gluco-Feed, NCT05167084: Acute Consequences Of Food-induced Glucocorticoid Secretion In Healthy Individuals

Completed

Europe

Metyrapone 250 mg Oral Tablets, Placebo 250 mg Tablets, Hydrocortisone 19,9mg s.c., pulsatile with a flow rate of 10μl/s, Placebo (0,9% NaCl solution)

Eleonora Seelig

Glucocorticoid Effect

06/23

SELCLAX, NCT04898894: Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

Recruiting

Venetoclax, Venclextra®, ABT-199, Selinexor, KPT-330, Cytarabine, Cytosine arabinoside, Ara-C, Cytosar®, Fludarabine, Fludara®, Fludarabine phosphate, 2-fluoro-ara-AMP, Filgrastim, G-CSF, Methotrexate, MTX, amethopterin, Trexall®, methotrexate/hydrocortisone/cytarabine, ITMHA, Intrathecal triples

St. Jude Children's Research Hospital, Karyopharm Therapeutics Inc, AbbVie, Gateway for Cancer Research

Acute Leukemia of Ambiguous Lineage in Relapse, Acute Myeloid Leukemia, in Relapse, Refractory Acute Leukemia of Ambiguous Lineage, Refractory Acute Myeloid Leukemia

07/23

07/25

MsSCORE, NCT03237689: Effects of Glucocorticoids on Cognition in HIV-infected Women

Completed

136

Hydrocortisone, Placebo Oral Tablet

Johns Hopkins University, National Institute of Mental Health (NIMH)

Hiv

09/23

MK-5684-001, NCT06136598: A Study of Opevesostat (MK-5684) in China Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Recruiting

RoW

Opevesostat, MK-5684, Dexamethasone, Dexamethasone acetate, Fludrocortisone, Fludrocortisone acetate, Hydrocortisone, Hydrocortisone acetate

Merck Sharp & Dohme LLC, Orion Corporation, Orion Pharma

Prostatic Neoplasms, Metastatic Castration-Resistant Prostate Cancer

04/26

10/27

NCT06177067: Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

Recruiting

Revumenib, SNDX-5613, Venetoclax, Venclextra®, Azacitidine, VIDAZA®, 5-azacitidine, intrathecal (IT) chemotherapy, ITMHA, methotrexate/hydrocortisone/cytarabine, Cytarabine, Ara-C, Cytosar®, Methotrexate, MTX, Trexall®

St. Jude Children's Research Hospital, Syndax Pharmaceuticals

Refractory Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia, Acute Leukemia of Ambiguous Lineage

01/26

07/26

NCT02303821 / 2014-001633-84: Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia

Active, not recruiting

130

Europe, Canada, US, RoW

Carfilzomib, PR-171, PR171, Kyprolis® (carfilzomib) for Injection, Dexamethasone, Mitoxantrone, PEG-asparaginase, Vincristine, Intrathecal (IT) Methotrexate, Intrathecal Triple Therapy (Intrathecal Cytarabine, Hydrocortisone, and Methotrexate), 6-Mercaptopurine, Cyclophosphamide, Cytarabine, Daunorubicin

Amgen, Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) - Study Design & Execution Collaborator, Innovative Therapies For Children with Cancer Consortium

Acute Lymphoblastic Leukemia (ALL)

07/24

COBRAS, NCT06430580: Cannabinoids and Biological Reactivity to Stress

Not yet recruiting

Hydrocortisone Oral, Yohimbine Hydrochloride, Cornstarch Placebo 20mg, Cornstarch Placebo 54mg

Auburn University, Wayne State University, National Institute on Drug Abuse (NIDA)

Cannabis Use Disorder

03/26

DUOC for MS, NCT04943289: Intrathecal Administration of DUOC-01 in Adults With Primary Progressive Multiple Sclerosis

Recruiting

DUOC-01

Joanne Kurtzberg, MD

Primary Progressive Multiple Sclerosis

08/25

NCT05919992: The Role of Glucocorticoids to Maintain Energy Homeostasis During Starvation (Gluco-Starve)

Recruiting

Europe

Metyrapone 250 mg Oral Tablets, Hydrocortisone 19.9mg s.c., pulsatile with a flow rate of 10μl/s, Placebo 250 mg Tablets, Placebo (0,9% NaCl solution)

Eleonora Seelig

Glucocorticoid Effect

08/24

NCT02574910: Androgen Reduction in Congenital Adrenal Hyperplasia, Phase 1

Suspended

Abiraterone acetate, Zytiga

University of Texas Southwestern Medical Center, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), University of Michigan, Children's Hospital Los Angeles

Congenital Adrenal Hyperplasia

01/25

NCT05476770: Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Recruiting

US, RoW

Tagraxofusp, Elzonris, Fludarabine, Cytarabine, Cytosar, Dexamethasone, Decadron, Vincristine, Oncovin, Azacitidine, AZA, Vidaza, Methotrexate, MTX, Amethopterin, Cytarabine IT, Hydrocortisone

Therapeutic Advances in Childhood Leukemia Consortium

Hematologic Malignancy, AML, ALL, BPDCN, MDS, Lymphoblastic Lymphoma, Lymphoma, B-Cell, Lymphoma, T-Cell, Hodgkin Lymphoma, Mixed Phenotype Acute Leukemia, Acute Undifferentiated Leukemia

11/25

11/27

MK-5684-005, NCT06104449: A Study of Opevesostat (MK-568)4 in Japanese Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC)

Active, not recruiting

Japan

Opevesostat, MK-5684, Dexamethasone, Decadron, Fludrocortisone acetate, Hydrocortisone

Merck Sharp & Dohme LLC, Orion Corporation, Orion Pharma

Prostatic Neoplasms, Metastatic Castration-Resistant Prostate Cancer

01/26

NCT05008146: Imaging CRF X NOP Interactions in CUD

Recruiting

Baseline [C-11]NOP-1A PET Scan, Hydrocortisone, Post-hydrocortisone [C-11]NOP-1A PET Scan

Rajesh Narendran, National Institute on Drug Abuse (NIDA)

Cocaine Use Disorder

09/28

ChiCTR-ICR-15007235: Dose hydrocortisone has effects on inhibiting inflammation and reducing hidden blood loss after total knee arthroplasty?

Not yet recruiting

N/A

low-dose hydrocortisone used after TKA

Department of Orthopaedics, West China Hospit; Department of Orthopaedics, West China Hospit, Natural Science Foundation of China

severe osteoarthritis of knee

ChiCTR1800018138: Hydrocortisone, Vitamin C, and Thiamine for the treatment of septic shock

Recruiting

N/A

180

Hydrocortisone, Vitamin C, and Thiamine ;normal saline

The First College of Clinical Medical Science, China Three Gorges University, Yichang; None, Self-raised funds

septic shock

HemaSur, NCT03688789: Hématologie Adulte Prevalence of Adrenal Insufficiency Post-chemotherapy Adrenocorticotropia in Adult Hematology

Withdrawn

N/A

200

Hydrocortisone supplementation

Rennes University Hospital

Haematological Malignancy

07/21

12/22

NCT04486521: Anti-IL6 and Corticosteroid Monotherapy vs Combination in COVID-19

Recruiting

N/A

860

RoW

Interleukin 6 (IL6) Antagonist, Tocilizumab, Siltuximab, Interleukin 6 (IL6) Antagonist and corticosteroids, corticosteroid alone

King Faisal Specialist Hospital & Research Center, Society of Critical Care Medicine

Critical Illness, Corona Virus Infection, Cytokine Release Syndrome

07/21

HAIRCUSH, NCT04201444: Hair Cortisol and Cushing's Disease

Completed

N/A

Europe

Patient group, Remission control group, Bilateral surrenalectomy control group

University Hospital, Bordeaux

Cushing Disease

06/22

ChiCTR2000040230: A randomized study on optimizing clinical outcomes of neonatal peri-cardiopulmoanry bypass period

Recruiting

N/A

240

methylprednisolone ;methylprdnisolone 15mg/kg twice ;hydrocortisone 75mg/kg twice ;none

Fuwai Hospital; Fuwai Hospital, Translational medicine fund of CAMS &PUMC

congenital heart disease

ChiCTR1900024864: Experimental regimen of hydrocortisone, vitamin C and thiamine in the treatment of severe sepsis and septic shock

Not yet recruiting

N/A

250

routine treatment ;routine treatment +Vitamin C ;routine treatment +Hydrocortisone ;routine treatment +Vitamin B1 ;routine treatment+Vitamin C+Hydrocortisone+Vitamin B1

Hebei Gereral Hospital; Hebei Gerneral Hospital, self-raised

Severe sepsis and septic shock

MiSaver®, NCT06353958: Stem Cell Treatment for Acute Myocardial Infarction

Completed

N/A

RoW

MiSaver

Honya Medical Inc, Chung Shan Medical University

Acute Myocardial Infarction

12/23

HYPER-AID, NCT03608943: Hydrocortisone Vs Prednisolone in AI

Recruiting

N/A

100

Europe

There is no specific intervention other than an individual changing their treatment as part of their usual care

Imperial College London

Adrenal Insufficiency

12/25

NCT04456439: Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)

Available

N/A

Remestemcel-L, Hydrocortisone, Diphenhydramine, Benadryl®

Mesoblast International Sàrl

Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)

NCT04991259: To Evaluate the Safety and Efficacy of Preemptive Administration of Continuous Renal Replacement Therapy in Patients With Acute Liver Failure With Cerebral Edema

Not yet recruiting

N/A

RoW

Continuous Renal Replacement Therapy (CRRT), Standard Medical Treatment

Institute of Liver and Biliary Sciences, India

Acute Liver Failure

06/23

NCT05974410: Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients

Available

N/A

AVM0703, Hydrocortisone, Proton pump inhibitor

AVM Biotechnology Inc

Glioblastoma, Squamous Cell Carcinoma, Hodgkin Lymphoma, Non-hodgkin Lymphoma, Breast Cancer, Prostate Cancer, Gastric Cancer, Ovarian Cancer, Acute Leukemia, Pancreatic Cancer, Spindle Cell Sarcoma, Cancer, Tumor, Solid, Tumor, Brain

NCT05919121: Effect Of Hydrocortisone Phonophoresis Versus Iontophoresis In Patients With Subacromial Impingement Syndrome

Recruiting

N/A

RoW

Therapeutic exercise, hydrocortisone phonophoresis, hydrocortisone iontophoresis

Horus University

Impingement Syndrome, Subacromial Impingement Syndrome

08/23

09/23

HYPO-DIAD, NCT05806190: Hypoglycaemia (Low Blood Sugar) in Adults With Diabetes and Adrenal Failure

Completed

N/A

Europe

Continuous Glucose Monitoring

Imperial College Healthcare NHS Trust

Diabetes Mellitus, Type 1, Adrenal Insufficiency, Diabetes Mellitus Type 2 - Insulin-Treated

08/23

09/23

IDROFLOG, NCT05724056: Idroflog® for Treatment of Dry Eye Disease

Not yet recruiting

N/A

130

Europe

Idroflog®, Study intervention, Sodium Hyaluronate 0.18% (Vismed®), Control intervention

Alfa Intes Industria Terapeutica Splendore s.r.l.

Dry Eye Disease

10/23

12/23

NCT06171932: Comparison Of Efficacy Of Hydrocortisone And Methyl Prednisolone In Acute Severe Asthma

Enrolling by invitation

N/A

RoW

Methylprednisolone,, Hydrocortisone

University of Karachi

Asthma Acute

08/24

TETRIS, NCT05212350: Total pancrEaTectomy vs High-Risk Pancreatic anastomosiS

Recruiting

N/A

Europe

Total pancreatectomy, Pancreatic anastomosis

Azienda Ospedaliera Universitaria Integrata Verona

Pancreatic Fistula

12/23

12/25

PREMILOCAP, NCT05451264: Study of the Effect of Hydrocortisone Administered for the Prevention of Pulmonary Bronchodysplasia (PREMILOC Trial) on the Determinants of Systemic Blood Pressure in Children

Recruiting

N/A

Europe

blood pressure measurement

Assistance Publique - Hôpitaux de Paris

Infant, Premature, Diseases

06/24

10/24

NCT05750797: The Nationwide Real-world Status of Oral Corticosteroid Use in Patients With Asthma

Not yet recruiting

N/A

800000

RoW

Oral corticosteroids

Joon Young Choi, Seoul St. Mary's Hospital, Hallym University Medical Center, Konkuk University Hospital

Asthma, Corticosteroid

12/23

NCT05165875: Splint Versus Steroid Randomized Trial

Not yet recruiting

N/A

100

Hydrocortisone-Lidocaine, Splint

National University Hospital, Singapore

De Quervain Syndrome

02/24

ChiCTR2200058331: Evaluation of the predictive efficacy of the vasoactivity-positive inotropic drug score for the timing of hydrocortisone treatment for septic shock in term infants

Not yet recruiting

N/A

Shock was treated with a vasoactive drug score of 59 without hydrocortisone ;Shock was treated with a vasoactive drug score of 59 and hydrocortisone

Guangdong Maternal and Child Health Hospital; Guangdong Maternal and Child Health Hospital, Science and technology project of Guangzhou

neonatal shock

POPS or POP02, NCT04278404: Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

Recruiting

N/A

5000

Canada, US

The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care:, Aminocaproic acid, Amiodarone, Bosentan, Budesonide, Cefdinir, Cefepime, Ceftazidime, Clindamycin, Clobazam, Dexamethasone, Dexmedetomidine, Dextroamphetamine/Amphetamine, Fosfomycin, Furosemide, Gabapentin, Guanfacine, Hydrocortisone, Labetalol, Meropenem, Metformin, Milrinone, Nalbuphine, Nicardipine, Nifedipine, Oseltamivir, Oxycodone, Risperidone, Sertraline, Sevelamer Carbonate / Sevelamer Hydrochloride, Spironolactone, Terbutaline, Tranexamic acid, Voriconazole, Zolpidem, Azithromycin, Lopinavir/Ritonavir, Ribavirin, Tocilizumab, Anakinra, Aspirin, Canakinumab, Colchicine, Interferon, Remdesivir, Ruxolitinib, Sarilumab, Abatacept, Infliximab

Duke University, The Emmes Company, LLC, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Coronavirus Infection (COVID-19), Pulmonary Arterial Hypertension, Urinary Tract Infections in Children, Hypertension, Pain, Hyperphosphatemia, Primary Hyperaldosteronism, Edema, Hypokalemia, Heart Failure, Hemophilia, Menorrhagia, Insomnia, Pneumonia, Skin Infection, Arrythmia, Asthma in Children, Bronchopulmonary Dysplasia, Adrenal Insufficiency, Fibrinolysis; Hemorrhage, Attention Deficit Hyperactivity Disorder, Multisystem Inflammatory Syndrome in Children (MIS-C), Kawasaki Disease, Coagulation Disorder, Down Syndrome

09/26

09/27

NCT06217939: Early Intravenous Hydrocortisone in Sepsis

Recruiting

N/A

230

RoW

Early hydrocortisone, Normal saline placebo, Open-label hydrocortisone

Siriraj Hospital

Sepsis Severe, Shock, Septic

06/25

09/25

ERETRIA, NCT05973604: Prevalence of Primary Aldosteronism in Atrial Fibrillation

Recruiting

N/A

120

Europe

Screening and Confirmatory diagnostic test for primary aldosteronism

Aristotle University Of Thessaloniki

Atrial Fibrillation, Primary Aldosteronism

09/24

RECORDS, NCT04280497 / 2020-000296-21: Rapid Recognition of Corticosteroid Resistant or Sensitive Sepsis

Recruiting

N/A

1800

Europe

Administration procedures

Assistance Publique - Hôpitaux de Paris, Institut National de la Santé Et de la Recherche Médicale, France, Versailles Saint-Quentin-en-Yvelines University, Université Paris-Saclay, Université Paris Est Créteil, Commissariat A L'energie Atomique, Beckman Coulter, Inc., Lumedix, Elice, Biothelis

Sepsis

10/24

INSCORT, NCT05716607: Treatment Study in Patients Treated With Both Insulin & Hydrocortisone

Not yet recruiting

N/A

Europe

OD dual-release Hydrocortisone, Once-daily dual-release hydrocortisone, TID Hydrocortisone, Thrice-daily conventional immediate-release hydrocortisone

Vastra Gotaland Region, The Gothenburg Society of Medicine, Åke Wibergs Stiftelse, Sahlgrenska University Hospital, Sweden, Pilloxa

Diabetes Mellitus, Adrenal Insufficiency, Polyglandular Autoimmune Syndrome

12/25

12/27

NCT05423613: Microneedling for Burn Hypertrophic Scars

Recruiting

N/A

Canada

Microneedling

Centre hospitalier de l'Université de Montréal (CHUM)

Burn Scar

06/25

06/26

NCT02785224: Arterial Pressure and Stress-Dose Steroids in Cardiac Arrest.

Not yet recruiting

N/A

191

Europe

Vasopressin Steroids Epinephrine, VSE

University of Athens, University of Thessaly

Cardiac Arrest

12/26

ACTRN12619001416189: Usefulness of static posturography with reference to established subjective clinical examination

Not yet recruiting

N/A

Bartosz Slomka

low back pain

ACTRN12612000234819: Effect of steroids on blood sugar levels and risk of heart disease in pituitary patients

Recruiting

N/A

Dr Morton Burt, Pfizer CVL Grant, Flinders Medical Centre Foundation

Secondary adrenal insufficiency, Hypopituitarism

NCT04567433: Days Alive and Out of Hospital for Patients With Sepsis

Completed

N/A

6213

RoW

Hydroxyethyl starch, Hydrocortisone, Early Goal Directed Therapy

The George Institute for Global Health, Australia

Sepsis, Septic Shock

02/24

ACTRN12619001455156: Efficacy of Tendon Strip Injections compared to sham following failure of conservative therapy for Achilles tendinopathy

Completed

N/A

192

Monash University, NHMRC

Achilles Tendinopathy



	Diseases Companies Products Productz Mechanisms of Action Sites